Spyre Therapeutics, Inc. (SYRE)

44.18 +0.97 (+2.24%) USD  |  NASDAQ  |  Feb 23, 16:00
44.96 +0.78 (+1.77%) Pre-Market: 08:47
More

Spyre Therapeutics Properties (Quarterly)

Properties (Quarterly) Chart

View Properties (Quarterly) for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Properties (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Properties (Quarterly) Range, Past 5 Years

View Properties (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Properties (Quarterly) Benchmarks

View Properties (Quarterly) Benchmarks
Start Trial
PTC Therapeutics, Inc. --
Tandem Diabetes Care, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. --
Alnylam Pharmaceuticals, Inc. --
Savara, Inc. --